Cargando…
Analysis of Spatial Heterogeneity of Responses in Metastatic Sites in Renal Cell Carcinoma Patients Treated with Nivolumab
Background: The purpose was to determine whether tumor response to CPI varies by organ and to characterize response patterns in a group of surgically treated metastatic RCC patients treated with Nivolumab. Methods: A retrospective analysis was undertaken between January 2016 and March 2020 on patien...
Autores principales: | Jajodia, Ankush, Goel, Varun, Patnaik, Nivedita, Pasricha, Sunil, Gupta, Gurudutt, Batra, Ullas, Talwar, Vineet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149819/ https://www.ncbi.nlm.nih.gov/pubmed/35645396 http://dx.doi.org/10.3390/tomography8030110 |
Ejemplares similares
-
Combined Diagnostic Accuracy of Diffusion and Perfusion MR Imaging to Differentiate Radiation-Induced Necrosis from Recurrence in Glioblastoma
por: Jajodia, Ankush, et al.
Publicado: (2022) -
Hyperprogression after Immunotherapy: Nivolumab. Analysis of Imaging Findings Associated with Hyperprogression and Tumor Growth Kinetics
por: Singla, Rishu, et al.
Publicado: (2021) -
Molecular Response Assessment with Immune Adaptive PERCIST in Lung Cancer Patients Treated with Nivolumab: Is It Better Than iRECIST?
por: Gupta, Manoj, et al.
Publicado: (2022) -
Large Symptomatic Sclerosing Pneumocytoma in a Young Male Smoker—A Rare and Deceptive Presentation
por: Pasricha, Sunil, et al.
Publicado: (2022) -
Case report: Non-small-cell lung carcinoma presenting as a foot swelling
por: John, Mithun Chacko, et al.
Publicado: (2015)